Evidence map›Paper›PMID 38733162›Full record

ArticleThe journals of gerontology. Series B, Psychological sciences and social sciences2024

Racial/Ethnic Disparities in Hospital Readmission and Frequent Hospitalizations Among Medicare Beneficiaries With Alzheimer's Disease and Related Dementia: Traditional Medicare Versus Medicare Advantage.

Elham Mahmoudi, Sara Margosian, Paul Lin

Abstract read
In one paragraph

Article in The journals of gerontology. Series B, Psychological sciences and social sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elham MahmoudiDepartment of Family Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0002-9746-8165
Sara MargosianDepartment of Family Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Paul LinInstitute for Healthcare Policy and Innovation, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Funding

Pilot CoreP30AG066582 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Julie PW Bynum · 2020 to 2026
$7.2M
Racial/Ethnic Disparities in Health Care and Challenges in Insurance Plan Choices among Older People with Alzheimer’s Disease and Related Dementia: A Mixed Methods Study of Medicare OptionsR01AG082856 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Elham Mahmoudi · 2023 to 2026
$2.2M
Using Machine Learning to Improve Readmission Prediction in Alzheimer's Disease and Related DementiaK01AG068361 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MAHMOUDI, ELHAM · 2020 to 2024
$651k
Alzheimer's Association Research Grant AARG-NTF-20-685960NIA NIH HHS K01 AG068361NIA NIH HHS P30 AG066582NIA NIH HHS R01 AG082856NIH HHS R01AG082856
6 · The paper itself

Abstract

objectivesExamine racial/ethnic disparities in 30-day readmission and frequent hospitalizations among Medicare beneficiaries with dementia in traditional Medicare (TM) versus Medicare Advantage (MA).

methodsIn this case-control study, we used 2018-2019 TM and MA claims data. Participants included individuals 65+ with 2 years of continuous enrollment, diagnosis of dementia, a minimum of 4 office visits in 2018, and at least 1 hospitalization in 2019, (cases: TM [n = 36,656]; controls: MA [n = 29,366]). We conducted matching based on health-need variables and applied generalized linear models adjusting for demographics, health-related variables, and healthcare encounters.

resultsTM was associated with higher odds of 30-day readmission (OR = 1.07 [CI: 1.02 to 1.12]) and frequent hospitalizations (OR = 1.10 [CI: 1.06 to 1.14]) compared to MA. Hispanic and Black enrollees in TM had higher odds of frequent hospitalizations compared with Hispanic and Black enrollees in MA, respectively (OR = 1.35 [CI: 1.19 to 1.54]) and (OR = 1.26 [CI: 1.13 to 1.40]). MA was associated with lower Hispanic-White and Black-White disparities in frequent hospitalizations by 5.8 (CI: -0.09 to -0.03) and 4.4 percentage points (PP; CI: -0.07 to -0.02), respectively. For 30-day readmission, there was no significant difference between Black enrollees in TM and MA (OR = 1.04 [CI: 0.92 to 1.18]), but Hispanic enrollees in TM had higher odds of readmission than Hispanics in MA (OR = 1.23 [CI: 1.06 to 1.43]). MA was associated with a lower Hispanic-White disparity in readmission by 1.9 PP (CI: -0.004 to -0.01). DISCUSSION: MA versus TM was associated with lower risks of 30-day readmission and frequent hospitalizations. Moreover, MA substantially reduced Hispanic-White and Black-White disparities in frequent hospitalizations compared with TM.

Indexed as

Alzheimer DiseaseHospitalizationMedicareMedicare Part CPatient ReadmissionAgedAged, 80 and overBlack or African AmericanCase-Control StudiesDementiaEthnicityFemaleHealthcare DisparitiesHispanic or LatinoHumansMaleAdverse health eventsDementiaDisparityMedicare options

Identifiers

PMID38733162
PMCPMC11212310

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.